These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24809889)

  • 21. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
    Schäd SG; Heitland P; Kühn-Velten WN; Gross GE; Jonas L
    J Cutan Pathol; 2013 Nov; 40(11):935-44. PubMed ID: 24102613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
    Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K
    Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
    Chen W; Huang SL; Huang CS; Tsai MC; Lai HM; Lui CC; Eng HL; Chang HW; Lee CH; Chuang FR
    Eur J Dermatol; 2009; 19(1):44-9. PubMed ID: 19059824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of NSF: New evidence challenging the prevailing theory.
    Newton BB; Jimenez SA
    J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation.
    Edgar E; Woltjer R; Whitham R; Gultekin SH; Watnick S; Cupler EJ
    Neuromuscul Disord; 2010 Jun; 20(6):411-3. PubMed ID: 20462761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
    J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation.
    Fuah KW; Lim CTS
    BMC Nephrol; 2017 Jul; 18(1):249. PubMed ID: 28738858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D; Johnsen H; Juelsrud A; Løvhaug D
    Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transglutaminases: the missing link in nephrogenic systemic fibrosis.
    Parsons AC; Yosipovitch G; Sheehan DJ; Sangüeza OP; Greenberg CS; Sane DC
    Am J Dermatopathol; 2007 Oct; 29(5):433-6. PubMed ID: 17890909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases.
    Song J; Volkov S; Shea CR; Alegre ML; Salgia R; Gregg K; Curran JJ; Woodruff J; Krausz T; Levine JS; Sweiss NJ
    J Cutan Pathol; 2009 Oct; 36 Suppl 1():31-4. PubMed ID: 19210585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.
    Heinz-Peer G; Neruda A; Watschinger B; Vychytil A; Geusau A; Haumer M; Weber M
    Eur J Radiol; 2010 Oct; 76(1):129-34. PubMed ID: 19619969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD; Bernheisel CR
    Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
    Thakral C; Abraham JL
    J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrogenic systemic fibrosis in the podiatric patient.
    Freed L; Hill J; Gooch D
    J Am Podiatr Med Assoc; 2012; 102(5):419-21. PubMed ID: 23001737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.
    Panesar M; Banerjee S; Barone GW
    Clin Transplant; 2008; 22(6):803-8. PubMed ID: 18713261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrogenic systemic fibrosis: what the hospitalist needs to know.
    Fine DM; Perazella MA
    J Hosp Med; 2010 Jan; 5(1):46-50. PubMed ID: 20063400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
    Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM
    Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study.
    Amet S; Launay-Vacher V; Clément O; Frances C; Tricotel A; Stengel B; Gauvrit JY; Grenier N; Reinhardt G; Janus N; Choukroun G; Laville M; Deray G
    Invest Radiol; 2014 Feb; 49(2):109-15. PubMed ID: 24169070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different time courses of nephrogenic systemic fibrosis: Is there a role for pharmacokinetic aspects in explaining a new clinical entity?
    Schmiedl S; Wesselmann U; Lehmann P; Haage P; Grebe SO
    Int J Clin Pharmacol Ther; 2009 Nov; 47(11):695-700. PubMed ID: 19840534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on nephrogenic systemic fibrosis: are we making progress?
    Haemel AK; Sadowski EA; Shafer MM; Djamali A
    Int J Dermatol; 2011 Jun; 50(6):659-66. PubMed ID: 21595657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.